Treatments for cystic fibrosis are evolving. Here’s a look at new CFTR modulator therapies including the most recent approval-elexacaftor/tezacaftor/ivacaftor (Trikafta).
Kimberly M. Dickinson, MD, MPH
Advertisement
Articles by Kimberly M. Dickinson, MD, MPH
Advertisement
Latest Updated Articles
Triple combination therapy for cystic fibrosis is here!Published: February 10th 2020 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD
2
Julie Khlevner, MD, AGAF, explains the impact of the FDA approval of linaclotide for pediatric IBS-C
3
Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency
4
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
5
